Johnson & Johnson JNJ Earnings Call Transcripts

NYSE JNJ
$274.11 +3.07 (+1.13%)
As of: Oct 29, 2026 · 2:30 PM EDT
23 earnings calls on file for Johnson & Johnson, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Johnson & Johnson Q3 2026 Earnings Call

Oct 13, 2026 9,684 words · 42 min read
  • Ryan KoorsVice President of Investor Relations
  • Joaquin DuatoChairman and Chief Executive Officer
  • Joseph J. WolkExecutive Vice President and Chief Financial Officer
  • Tom CavanaughExecutive Vice President, Worldwide Chairman, Innovative Medicine
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Johnson & Johnson Earnings Call Transcripts

Calls23
LatestOct 13, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 23 Johnson & Johnson transcripts Register to get access to Johnson & Johnson’s earnings call transcripts.